AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies (Q91735298)
Jump to navigation
Jump to search
scientific article published on 25 September 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies |
scientific article published on 25 September 2018 |
Statements
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies (English)
Sean Caenepeel
Brian Belmontes
Gordon Moody
Kathleen S Keegan
Danny Chui
Douglas A Whittington
Xin Huang
Leszek Poppe
Alan C Cheng
Mario Cardozo
Jonathan Houze
Yunxiao Li
Brian Lucas
Xianghong Wang
Joshua P Taygerly
Marc Vimolratana
Manuel Zancanella
Liusheng Zhu
Elaina Cajulis
Tao Osgood
Jan Sun
Regina K Egan
Joseph D McClanaghan
Jianan Gong
Donia Moujalled
Giovanna Pomilio
Pedro Beltran
Andrew Wei
Jude Canon
Angela Coxon